冬凌草甲素的结构修饰与生物活性研究进展

冬凌草甲素为对映贝壳杉烷类二萜化合物,主要分布在中草药冬凌草及相关植物中,具有多种生物活性如抗肿瘤、抗菌、抗炎等.主要综述了2000年以来冬凌草甲素的多功能结构修饰,表明冬凌草甲素结构修饰是提高冬凌草甲素药理活性的一种有效途径.     

贵州冬凌草的对映－贝壳杉烷二萜化合物

从贵州产冬凌草[Isodon rubescens (Hemsl.) Hera]中分离得到12个6，7－断 裂－7，20－内酯－对映－贝壳杉烷二萜化合物，经波谱分析鉴定了它们的结构， 其中有7个新化合物，分别命名为贵州冬凌草乙素～辛素（guidongnins B～H, 1～ 7)，以及卢氏冬凌草甲素（8）、卢氏冬凌草乙素（9）、贵州冬凌草素（10）、狭 叶香茶菜素(angustifolin, 11)和6－表香茶菜素（6-epiangustifolin, 12)等5个 已知化合物。另外，将作者原命名的贵州冬凌草素（guidongnin, 10）更名为贵州 冬凌草甲素(guidongnin A, 10)，并利用二维核磁区振波谱技术修订了卢氏冬凌草 乙素的结构。     

贵州冬凌草的对映－贝壳杉烷二萜化合物

从贵州产冬凌草[Isodon rubescens (Hemsl.) Hera]中分离得到12个6，7－断 裂－7，20－内酯－对映－贝壳杉烷二萜化合物，经波谱分析鉴定了它们的结构， 其中有7个新化合物，分别命名为贵州冬凌草乙素～辛素（guidongnins B～H, 1～ 7)，以及卢氏冬凌草甲素（8）、卢氏冬凌草乙素（9）、贵州冬凌草素（10）、狭 叶香茶菜素(angustifolin, 11)和6－表香茶菜素（6-epiangustifolin, 12)等5个 已知化合物。另外，将作者原命名的贵州冬凌草素（guidongnin, 10）更名为贵州 冬凌草甲素(guidongnin A, 10)，并利用二维核磁区振波谱技术修订了卢氏冬凌草 乙素的结构。     

冬凌草甲素葡萄糖苷的合成

为研究冬凌草甲素的构效关系,合成生物活性更高的化合物,以冬凌草甲素为先导化合物,通过对其进行选择性保护,再进行糖苷化,最后脱保护,经五步反应,以23.0%的总收率,合成了冬凌草甲素-6-O-β-D-葡萄糖苷,并得到一系列冬凌草甲素衍生物,它们的结构经IR,1H NMR,MS和元素分析确证.     

冬凌草甲素和冬凌草乙素与谷胱苷肽的迈克尔加成反应

采用紫外光谱动力学方法测定了抗肿瘤对映贝壳杉烯二萜冬凌草甲素和冬凌草乙素与谷胱苷肽迈克尔加成反应的级数、速率常数和平衡常数.结果表明,冬凌草甲素和冬凌草乙素与与谷胱苷肽迈克尔加成反应符合二级动力学方程,25℃下的速率常数分别为16.196 0L·(mol·s)-1和7.480 5L·(mol·s)-1,平衡常数分别为177.98L/mol和85.60L/mol.冬凌草甲素与谷胱苷肽迈克尔加成反应速率和反应程度均比冬凌草乙素的大得多,反应活性更好.对映贝壳杉烯二萜通过与机体发生迈克尔加成反应而产生抗肿瘤作用;因此,冬凌草甲素可能比冬凌草乙素具有更好的抗肿瘤活性.     

冬凌草甲素的电化学性质及电分析方法研究

研究了抗癌药物冬凌草甲素在悬汞电极上的电化学行为。在NaAc-NaOH(pH 7.8)的缓冲溶液中,冬凌草甲素有一受吸附控制的还原峰,峰电位为-1.150 V,峰电流与冬凌草甲素浓度在7.25×10-7~1.01×10-5mol/L范围内有良好的线性关系,检出限为1.45×10-7mol/L(S/N=3)。对冬凌草片剂实际样品中冬凌草甲素含量测定,结果满意。     

抗癌药物冬凌草甲素的分子构型研究

本文用同核化学位移相关谱和二维J分解谱归属了冬凌草甲素的^1H谱, 测定了所有的质子标量偶合常数, 根据一系列的Karplus公式计算了二面角, 用自编WUPH计算程序, 计算出冬凌草甲素的分子构型。     

高效液相色谱法测定血液中冬凌草甲素的含量

冬凌草甲素(Rubescensin A,以下简称甲素),是从植物冬凌草中经提取分离出的一种抗癌有效成分。它具有多方面的药理作用,目前临床上用于治疗食管癌、肝癌和胰腺癌等。为给临床合理用药提供理论依据,研究甲素的动力学特性,准确测出服药后血液中甲素浓度随时间变化的规律显得十分重要。对药物和生理体液中微量成分的分离和测定,目前大部分都采用高效液相色谱法。但血液中甲素的高效液相色谱测定,国     

信阳冬凌草甲素和乙素的结构研究

从河南省信阳地区产冬凌草叶中分得两种新的对映一贝壳杉烯型二萜化合物,命名为信阳冬凌草甲素和乙素,经光谱和化学方法证明,它们的结构分别为1和2。     

冬凌草中的新对映-贝壳杉烷二萜化合物

对河南省济源地区产冬凌草[Isodon rubescens(Hemsl.)Hara]再次进行了深入 的研究，从其叶的乙酸乙酯提取物中分离得到了16个化合物，其中1和2为两个新的 7，20-环氧-对映-贝壳杉烷类二萜化合物，其结构通过波谱分析确定为16（S）-羟 甲基-1α，6β，7β，11β-甲羟基-7α，20-环氧-对映-贝壳杉烷-15-酮（1）和 16（R）-羟甲基-1α，6β，7β，14β-四羟基-7α，20-环氧-对映-贝壳杉烷-15- 酮（2），分别命名为冬凌草已素（1）和庚素（2）；其余的已知化合物分别鉴定 为lasiodonin（3），冬凌草甲素（oridonin，4），乙素（ponicidin），丙素（ rubescensin C），丁素（rubescensin D），牛尾草丙素（rabdoternin C），荛 花香茶菜乙素（wikstroemioidin B），enmenol-1α-O-β-D-glucoside， enmenol，胡麻素（pedalitin），水杨酸，乌索酸，β-谷甾醇和胡萝卜甙。     

Isolation and purification of oridonin from Rabdosia rubescens using upright counter-current chromatography

A preparative counter-current chromatography (CCC) method for isolation and purification of oridonin, a new cancer chemoprevention agent, from the Chinese medicinal plant Rabdosia rubescens was successfully established. The crude oridonin was obtained by elution with a light petroleum/acetone solvent mixture from ethanol extracts of R. rubescens using column chromatography on silica gel. With a two-phase solvent system composed of n-hexane/ethyl acetate/methanol/water (1:2:1:2, v/v), 120 mg of oridonin at the purity of 97.8% was obtained from 200 mg of the crude sample in a single-step CCC separation. The structure of oridonin was identified by ESI-MS, 1H NMR, and 13C NMR.     

NMR spectra and structures of oridonin derivatives complexes with β‐cyclodextrin

Complexations between three oridonin derivatives and β‐cyclodextrin (βCD) were studied by nuclear magnetic resonance (NMR) method. Job's plots for complexes were depicted by ¹H NMR spectra chemical shifts, which proved the 1:1 stoichiometry inclusion complex formation between each derivative and βCD. Two‐dimensional rotating frame overhauser effect spectroscopy (2D ROESY) support the above conclusion and also proved that ring A of each oridonin derivative deeply enters into hydrophobic cavity from the wider rim and the other parts are outside the cavity. Apparent formation constants (K_a) of complexes between three oridonin derivatives and two CDs are calculated according to Scott's equation. Copyright © 2011 John Wiley & Sons, Ltd.     

An Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential

Cancer is one of the leading causes of death worldwide, with a mortality rate of more than 9 million deaths reported in 2018. Conventional anti-cancer therapy can greatly improve survival however treatment resistance is still a major problem especially in metastatic disease. Targeted anti-cancer therapy is increasingly used with conventional therapy to improve patients’ outcomes in advanced and metastatic tumors. However, due to the complexity of cancer biology and metastasis, it is urgent to develop new agents and evaluate the anti-cancer efficacy of available treatments. Many phytochemicals from medicinal plants have been reported to possess anti-cancer properties. One such compound is known as oridonin, a bioactive component of Rabdosia rubescens. Several studies have demonstrated that oridonin inhibits angiogenesis in various types of cancer, including breast, pancreatic, lung, colon and skin cancer. Oridonin’s anti-cancer effects are mediated through the modulation of several signaling pathways which include upregulation of oncogenes and pro-angiogenic growth factors. Furthermore, oridonin also inhibits cell migration, invasion and metastasis via suppressing epithelial-to-mesenchymal transition and blocking downstream signaling targets in the cancer metastasis process. This review summarizes the recent applications of oridonin as an anti-angiogenic and anti-metastatic drug both in vitro and in vivo, and its potential mechanisms of action.     

Isolation and purification of oridonin from the whole plant of Isodon rubescens by high-speed counter-current chromatography

Semi-preparative high-speed counter-current chromatography (HSCCC) was successfully used for isolation and purification of oridonin from Isodon rubescens by using a two-phase-solvent system composed of n-hexane-ethyl acetate-methanol-water (2.8:5:2.8:5, v/v/v/v). The targeted compound isolated, collected and purified by HSCCC was analyzed by high performance liquid chromatography (HPLC). A total of 40.6 mg of oridonin with the purity of 73.5% was obtained in less than 100 min from 100 mg of crude Isodon rubescens extract. The chemical structure of the compound was identified by IR, 1H-NMR and 13C-NMR.     

The stereo-, regio-, and chemo-selective conversion of diterpenoids, kamebakaurin to oriaonin.

In this paper, we report the first stereo-, regio-, and chemo-selective conversion of oridonin from kamebakaurin. The overall yield in 7 steps is 9%.     

THE STEREO-, REGIO-, AND CHEMO-SELECTIVE CONVERSION OF DITERPENOIDS, Kamebakaurin TO Oriaonin

In this paper, we report the first stereo-, regio-, and chemo-selective conversion of oridonin (1) from kamebakaurin (3). The overall yield in 7 steps is 9%.     

Formal synthesis of semiaquilegin A

A formal synthesis of semiaquilegin A is achieved starting from readily available oridonin in 19 linear steps. The absolute configuration of the natural product has been established. A variety of useful analogues were prepared through this synthetic route.     

Effective two-dimensional counter-current chromatographic method for simultaneous isolation and purification of oridonin and ponicidin from the crude extract of Rabdosia rubescens

A preparative two-dimensional counter-current chromatographic system (2D-CCC) for simultaneous separation and purification of oridonin and ponicidin from the crude extract of Rabdosia rubescens was presented. It was based on the use of a high-speed CCC (HSCCC, total column volume V(c)=146ml) instrument in the first dimension (1st-D) and a preparative upright CCC (UCCC, V(c)=1500ml) column in the second dimension (2nd-D). The interface was a homemade column-switching system with a 50-ml sample loop. In this way, almost the whole interested region from the first dimension was transferred on-line to the second dimension for further separation. The use of a pair of two-phase solvent systems composed of n-hexane-ethyl acetate-methanol-water (1:5:1:5 and 3:5:3:5, v/v) in the two dimensions permitted the simultaneous separation of oridonin and ponicidin, making this 2D-CCC system with satisfactory resolution and peak capacity. During about 9h separation, two injections with about a 250mg amount of the crude extract for each, was accomplished using this 2D-CCC system, yielding 60mg of oridonin (1) and 10mg of ponicidin (2) all at a purity of over 95% as determined by HPLC analysis. Their chemical structures were identified by electrospray ionization (ESI) MS, (1)H NMR and (13)C NMR.